PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BCAT vs. BRASX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between BCAT and BRASX is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.2

Performance

BCAT vs. BRASX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BlackRock Capital Allocation Trust (BCAT) and BlackRock Allocation Target Shares Series S Portfolio (BRASX). The values are adjusted to include any dividend payments, if applicable.

5.00%10.00%15.00%20.00%NovemberDecember2025FebruaryMarchApril
11.62%
10.02%
BCAT
BRASX

Key characteristics

Sharpe Ratio

BCAT:

0.55

BRASX:

3.06

Sortino Ratio

BCAT:

0.91

BRASX:

5.81

Omega Ratio

BCAT:

1.12

BRASX:

1.81

Calmar Ratio

BCAT:

0.57

BRASX:

6.90

Martin Ratio

BCAT:

2.92

BRASX:

20.77

Ulcer Index

BCAT:

3.04%

BRASX:

0.32%

Daily Std Dev

BCAT:

16.04%

BRASX:

2.19%

Max Drawdown

BCAT:

-36.13%

BRASX:

-10.61%

Current Drawdown

BCAT:

-8.52%

BRASX:

-0.43%

Returns By Period

In the year-to-date period, BCAT achieves a -2.31% return, which is significantly lower than BRASX's 1.47% return.


BCAT

YTD

-2.31%

1M

-5.59%

6M

-5.68%

1Y

10.08%

5Y*

N/A

10Y*

N/A

BRASX

YTD

1.47%

1M

0.50%

6M

2.20%

1Y

6.81%

5Y*

2.79%

10Y*

2.55%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BCAT vs. BRASX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BCAT
The Risk-Adjusted Performance Rank of BCAT is 7373
Overall Rank
The Sharpe Ratio Rank of BCAT is 7575
Sharpe Ratio Rank
The Sortino Ratio Rank of BCAT is 6767
Sortino Ratio Rank
The Omega Ratio Rank of BCAT is 6565
Omega Ratio Rank
The Calmar Ratio Rank of BCAT is 7777
Calmar Ratio Rank
The Martin Ratio Rank of BCAT is 8080
Martin Ratio Rank

BRASX
The Risk-Adjusted Performance Rank of BRASX is 9898
Overall Rank
The Sharpe Ratio Rank of BRASX is 9898
Sharpe Ratio Rank
The Sortino Ratio Rank of BRASX is 9898
Sortino Ratio Rank
The Omega Ratio Rank of BRASX is 9797
Omega Ratio Rank
The Calmar Ratio Rank of BRASX is 9898
Calmar Ratio Rank
The Martin Ratio Rank of BRASX is 9898
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BCAT vs. BRASX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for BlackRock Capital Allocation Trust (BCAT) and BlackRock Allocation Target Shares Series S Portfolio (BRASX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BCAT, currently valued at 0.55, compared to the broader market-2.00-1.000.001.002.003.00
BCAT: 0.55
BRASX: 3.06
The chart of Sortino ratio for BCAT, currently valued at 0.91, compared to the broader market-6.00-4.00-2.000.002.004.00
BCAT: 0.91
BRASX: 5.81
The chart of Omega ratio for BCAT, currently valued at 1.12, compared to the broader market0.501.001.502.00
BCAT: 1.12
BRASX: 1.81
The chart of Calmar ratio for BCAT, currently valued at 0.57, compared to the broader market0.001.002.003.004.00
BCAT: 0.57
BRASX: 6.90
The chart of Martin ratio for BCAT, currently valued at 2.92, compared to the broader market-5.000.005.0010.0015.0020.00
BCAT: 2.92
BRASX: 20.77

The current BCAT Sharpe Ratio is 0.55, which is lower than the BRASX Sharpe Ratio of 3.06. The chart below compares the historical Sharpe Ratios of BCAT and BRASX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00NovemberDecember2025FebruaryMarchApril
0.55
3.06
BCAT
BRASX

Dividends

BCAT vs. BRASX - Dividend Comparison

BCAT's dividend yield for the trailing twelve months is around 23.98%, more than BRASX's 4.59% yield.


TTM20242023202220212020201920182017201620152014
BCAT
BlackRock Capital Allocation Trust
23.98%17.50%10.11%9.00%6.42%0.48%0.00%0.00%0.00%0.00%0.00%0.00%
BRASX
BlackRock Allocation Target Shares Series S Portfolio
4.59%4.59%4.06%2.66%1.61%2.66%3.08%2.24%2.88%3.36%3.26%1.78%

Drawdowns

BCAT vs. BRASX - Drawdown Comparison

The maximum BCAT drawdown since its inception was -36.13%, which is greater than BRASX's maximum drawdown of -10.61%. Use the drawdown chart below to compare losses from any high point for BCAT and BRASX. For additional features, visit the drawdowns tool.


-14.00%-12.00%-10.00%-8.00%-6.00%-4.00%-2.00%0.00%NovemberDecember2025FebruaryMarchApril
-8.52%
-0.43%
BCAT
BRASX

Volatility

BCAT vs. BRASX - Volatility Comparison

BlackRock Capital Allocation Trust (BCAT) has a higher volatility of 9.13% compared to BlackRock Allocation Target Shares Series S Portfolio (BRASX) at 0.84%. This indicates that BCAT's price experiences larger fluctuations and is considered to be riskier than BRASX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%2.00%4.00%6.00%8.00%10.00%NovemberDecember2025FebruaryMarchApril
9.13%
0.84%
BCAT
BRASX
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab